BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2896 related articles for article (PubMed ID: 25554985)

  • 21. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
    Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of curcumin-induced gastroprotection against ethanol-induced gastric mucosal lesions.
    Czekaj R; Majka J; Magierowska K; Sliwowski Z; Magierowski M; Pajdo R; Ptak-Belowska A; Surmiak M; Kwiecien S; Brzozowski T
    J Gastroenterol; 2018 May; 53(5):618-630. PubMed ID: 28856444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of cyclooxygenase-1 and cyclooxygenase-2 activity in the therapeutic effect of ghrelin in the course of ethanol-induced gastric ulcers in rats.
    Warzecha Z; Ceranowicz P; Dembinski M; Cieszkowski J; Ginter G; Ptak-Belowska A; Dembinski A
    J Physiol Pharmacol; 2014 Feb; 65(1):95-106. PubMed ID: 24622834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin independent protective role of l-tryptophan in experimental reflux esophagitis in rats.
    Singh P; Singh N; Ahmad A; Singh O; Palit G
    Pharmacol Res; 2011 Sep; 64(3):249-57. PubMed ID: 21527345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
    J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of lactoferrin on acute acid reflux-induced esophageal mucosal damage.
    Inamori M; Togawa J; Matsumoto S; Harad K; Matsuura M; Iida H; Akimoto K; Endo H; Nonaka T; Takahashi H; Koide T; Shibata W; Ida T; Kusakabe A; Nagase H; Tominaga S; Tanaka K; Gotoh E; Nakajima A; Maeda S
    Hepatogastroenterology; 2014 Sep; 61(134):1595-600. PubMed ID: 25436348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves.
    Pajdo R; Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Sliwowski Z; Pawlik M; Ptak A; Drozdowicz D; Hahn EG
    Eur J Pharmacol; 2001 Sep; 427(3):263-76. PubMed ID: 11567657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon Monoxide (CO) Released from Tricarbonyldichlororuthenium (II) Dimer (CORM-2) in Gastroprotection against Experimental Ethanol-Induced Gastric Damage.
    Magierowska K; Magierowski M; Hubalewska-Mazgaj M; Adamski J; Surmiak M; Sliwowski Z; Kwiecien S; Brzozowski T
    PLoS One; 2015; 10(10):e0140493. PubMed ID: 26460608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.
    Brzozowski T; Konturek PC; Pajdo R; Kwiecień SN; Konturek S; Targosz A; Burnat G; Cieszkowski J; Pawlik WW; Hahn EG
    Inflammopharmacology; 2005; 13(1-3):317-30. PubMed ID: 16259750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Curculigo orchioides on reflux esophagitis by suppressing proinflammatory cytokines.
    Ku SK; Kim JS; Seo YB; Kim YU; Hwang SL; Lee YC; Yang CH; Kim HY; Seo BI; Park JH; Min YH; Roh SS
    Am J Chin Med; 2012; 40(6):1241-55. PubMed ID: 23227795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
    Regul Pept; 1999 Jun; 82(1-3):19-33. PubMed ID: 10458643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of brain-gut axis in healing of gastric ulcers.
    Konturek PC; Brzozowski T; Burnat G; Kwiecien S; Pawlik T; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):179-92. PubMed ID: 15082877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-gut axis in gastroprotection by leptin and cholecystokinin against ischemia-reperfusion induced gastric lesions.
    Brzozowski T; Konturek PC; Pajdo R; Kwiecień S; Ptak A; Sliwowski Z; Drozdowicz D; Pawlik M; Konturek SJ; Hahn EG
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):583-602. PubMed ID: 11787760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between selective cyclooxygenase inhibitors and capsaicin-sensitive afferent sensory nerves in pathogenesis of stress-induced gastric lesions. Role of oxidative stress.
    Kwiecien S; Konturek PC; Sliwowski Z; Mitis-Musiol M; Pawlik MW; Brzozowski B; Jasnos K; Magierowski M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2012 Apr; 63(2):143-51. PubMed ID: 22653901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants.
    Lee JS; Oh TY; Ahn BO; Cho H; Kim WB; Kim YB; Surh YJ; Kim HJ; Hahm KB
    Mutat Res; 2001 Sep; 480-481():189-200. PubMed ID: 11506813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis.
    Inamori M; Shimamura T; Nagase H; Abe Y; Umezawa T; Nakajima A; Saito T; Ueno N; Tanaka K; Sekihara H; Togawa J; Kaifu H; Tsuboi H; Kayama H; Tominaga S
    Hepatogastroenterology; 2006; 53(69):361-5. PubMed ID: 16795973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
    Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
    J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin protects against experimental reflux esophagitis.
    Lahiri S; Singh P; Singh S; Rasheed N; Palit G; Pant KK
    J Pineal Res; 2009 Mar; 46(2):207-13. PubMed ID: 19067786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 145.